Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Bradmer Pharmaceuticals Inc. (T.GLX) had Weighted-Average Shares Outstanding (Diluted) of 0.16M for the most recently reported fiscal quarter, ending 2018-03-31.
| Income Statement Financials | |
-- |
|
-0.35M |
|
-- |
|
-- |
|
-- |
|
-0.35M |
|
-- |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
0.16M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.16M |
-2.24 |
|
-2.24 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.34M |
|
-- |
|
-- |
|
-- |
|
0.41M |
|
-0.07M |
|
-0.07M |
|
-0.07M |
|
0.16M |
|
| Cash Flow Statement Financials | |
-0.07M |
|
-- |
|
-- |
|
0.40M |
|
0.34M |
|
-0.07M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
486.53% |
|
486.53% |
|
-100.58% |
|
486.53% |
|
-0.46 |
|
-0.44 |
|
-0.44 |
|